Pfizer Plans Workforce Reduction in Switzerland as Part of Cost-Saving Strategy

Pfizer is planning to reduce its workforce in Switzerland as part of a broader, multi-year cost-reduction programme, according to media reports. The move could result in more than 200 job cuts, with the company’s Swiss operations expected to shrink from around 300 employees to about 70 by the end of the year.
The workforce reduction forms part of Pfizer’s efforts to achieve approximately $7 billion in cost savings over the next two years. The company has said the strategy focuses on streamlining operations, simplifying internal processes and reallocating resources toward higher-impact areas to improve efficiency and productivity.
Pfizer aims to adopt operating models and strategies that support the efficient delivery of medicines to patients while optimising costs. The restructuring reflects a wider effort to align operations with changing business priorities and market conditions.
The planned cuts in Switzerland follow earlier workforce reductions at other Pfizer locations. In August, around 100 roles were reported to be at risk at the company’s Bothell, Washington facility as part of initiatives to improve research and development productivity. In June 2025, Pfizer also reportedly reduced its workforce in San Diego by 56 positions. These measures were linked to efficiency improvements, increased automation and greater use of digital technologies.
Pfizer is among several major pharmaceutical companies that have announced job cuts this year, alongside firms such as Bayer, Roche and Moderna, amid ongoing cost pressures and shifts in the global pharmaceutical industry.
The post Pfizer Plans Workforce Reduction in Switzerland as Part of Cost-Saving Strategy appeared first on HR Talk.
​